Cellectar Biosciences, Inc. (NASDAQ:CLRB) Announces Additional US Patents Granted as Share Price Advances on News

Cellectar Biosciences, Inc. (NASDAQ:CLRB) Announces Additional US Patents Granted as Share Price Advances on News

Oncology-focused clinical stage biotechnology company, Cellectar Biosciences, Inc. (NASDAQ:CLRB), has announced a new patent which covers two of their lead compounds. MADISON, Wis., Jan. 24, 2017 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (CLRB), an oncology-focused clinical stage biotechnology company, today announces that the United States Patent and Trademark Office (“USPTO”) has granted patent number 9,550,002, which covers method of use for the company’s lead compound, CLR 131, as well as […]

Read More ˃